Skip to main content
Log in

Serumfolsäurespiegel unter antiepileptischer Langzeittherapie

Serum folic acid in anticonvulsant long term therapy

  • Published:
Archiv für Psychiatrie und Nervenkrankheiten Aims and scope Submit manuscript

Summary

No significant difference was found in a comparison between the values of unreduced serum folic acid of 48 epileptics treated with hydantoin and 38 controls as measured by a competitive protein-binding assay. The average folic acid value was 7.73 nmol/l in the epileptics, a little higher than the 7.18 nmol/l found in the controls. This result supports the hypothesis that the folate deficiency in epileptics is caused by blocking the conversion of folic acid to 5-methyltetrahydrofolic acid by phenytoin.

Zusammenfassung

Bei einem Vergleich der mit Hilfe der kompetitiven Protein-Bindungs-Analyse gemessenen Werte der unreduzierten Folsäure im Serum zwischen 48 mit Hydantoin behandelten Epileptikern und 38 Normalpersonen ergab sich kein signifikanter Unterschied der Mittelwerte. Durchschnittlich lag der Folsäurespiegel bei den Epileptikern mit 7,73 nmol/l gegenüber 7,18 nmol/l bei den Kontrollpersonen etwas höher. Dieser Befund stützt die Hypothese, daß der Folatmangel bei Epileptikern auf einer Blockierung der Umwandlung von Folsäure in 5-Methyltetrahydrofolsäure durch Diphenylhydantoin beruht.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Child, J. A., Khattak, B. Z., Knowles, J. P.: Macrocytosis in patients on anticonvulsant drugs. Br. J. Haematol. 16, 451–455 (1969)

    Google Scholar 

  2. Davis, R. E., Reed, P. A., Smith, B. K.: Serum pyridoxal, folate, and vitamin B 12 levels in institutionalized epileptics. Epilepsia 16, 463–468 (1975)

    Google Scholar 

  3. Dunn, R. T., Foster, L. B.: Radioassay of serum folate. Clin. Chem. 19, 1101–1105 (1973)

    Google Scholar 

  4. Fehling, C., Jagerstad, M., Lindstrand, K., Westesson, A. K.: The effect of anticonvulsant therapy upon the absorption of folates. Clin. Sci. 44, 595–600 (1973)

    Google Scholar 

  5. Herbert, V., Zalusky, R.: Selective concentration of folic acid acitivity in cerebrospinal fluid. Fed. Proc. 20, 453 (1961)

    Google Scholar 

  6. Hoffbrand, A. V., Necheles, T. F.: Mechanism of folate deficiency in patients receiving phenytoin. Lancet 2, 528–530 (1968)

    Google Scholar 

  7. Horwitz, S. J., Klipstein, F. A., Lovelace, R. E.: Relation of abnormal folate metabolism to neuropathy developing during anticonvulsant drug therapy. Lancet 1, 563–565 (1968)

    Google Scholar 

  8. Ibbotson, R. N., Dilena, B. A., Horwood, J. M.: Studies on deficiency and absorption of folates in patients on anticonvulsant drugs. Australas. Ann. Med. 16, 144–150 (1967)

    Google Scholar 

  9. Jensen, O. N., Olesen, O. V.: Folic acid and anticonvulsive drugs. Arch. Neurol. 21, 208–214 (1969)

    Google Scholar 

  10. Klipstein, F. A.: Subnormal serum folate and macrocytosis associated with anticonvulsant drug therapy. Blood 23, 68–86 (1964)

    Google Scholar 

  11. Levitt, M., Nixon, P. F., Pincus, J., Bertino, J. R.: Transport characteristics of folates in cerebrospinal fluid: A study using doubly labeled 5-methyltetrahydrofolate and 5-formyltetrahydrofolate. J. Clin. Invest. 50, 1301–1308 (1971)

    Google Scholar 

  12. Malpas, J. S., Spray, G. H., Witts, L. J.: Serum folic acid and vitamin B12 levels in anticonvulsant therapy. Br. Med. J. 1, 955–957 (1966)

    Google Scholar 

  13. Mannheimer, E., Pakesch, F., Reimer, E. E., Vetter, H.: Die hämatologischen Komplikationen der Epilepsiebehandlung mit Hydantoinkörpern. Med. Klin. 47, 1397–1401 (1952)

    Google Scholar 

  14. Mattson, R. H., Gallagher, B. B., Reynolds, E. H., Glass, D.: Folate therapy in epilepsy. Arch. Neurol. 29, 78–81 (1973)

    Google Scholar 

  15. Nelson, E. W., Gerda, J. J., Wilder, B. J., Streiff, R. R.: Effect of diphenylhydantoin on the bioavailability of citrus folate. Am. J. Clin. Nutr. 31, 82–87 (1978)

    Google Scholar 

  16. Preece, J., Reynolds, E. H., Johnson, A. L.: Relationship of serum to red cell folate concentrations in drug treated epileptic patients. Epilepsia 2, 335–340 (1971)

    Google Scholar 

  17. Reynolds, E. H., Milner, G., Matthews, D. M., Chanarin, L.: Anticonvulsant therapy, megaloblastic haemopoiesis and folic acid metabolism. Quart. J. Med. 35, 521–537 (1966)

    Google Scholar 

  18. Rothenberg, S. P., Dacosta, M., Rosenberg, Z.: A radioassay for serum folate: Use of a twophase sequential incubation, ligand-binding system. New Engl. J. Med. 286, 1335–1339 (1972)

    Google Scholar 

  19. Snaith, R. P., Mehta, S., Raby, A. H.: Serum folate and vitamin B12 in epileptics with and without mental illness. Br. J. Psychiatr. 116, 179–183 (1970)

    Google Scholar 

  20. Taguchi, C.: Clinical and experimental studies on folic acid deficiency due to anticonvulsants. II. Investigations on patients receiving anticonvulsants and experimental study on the effect of diphenylhydantoin on the absorption of folic acid in rats. Acta Med. Okayama 25, 551–566 (1971)

    Google Scholar 

  21. Woodbury, D. M., Kemp, J. W.: Pharmacology and mechanisms of action of diphenylhydantoin. Psychiatr. Neurol. Neurochir. 74, 91–115 (1971)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krause, K.H., Schmidt-Gayk, H., Gutscher, D. et al. Serumfolsäurespiegel unter antiepileptischer Langzeittherapie. Arch. Psychiatr. Nervenkr. 228, 91–94 (1980). https://doi.org/10.1007/BF00365747

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00365747

Key words

Schlüsselwörter

Navigation